De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7863-8. doi: 10.1073/pnas.0906232107. Epub 2010 Apr 12.

Abstract

Schizophrenia likely results from poorly understood genetic and environmental factors. We studied the gene encoding the synaptic protein SHANK3 in 285 controls and 185 schizophrenia patients with unaffected parents. Two de novo mutations (R1117X and R536W) were identified in two families, one being found in three affected brothers, suggesting germline mosaicism. Zebrafish and rat hippocampal neuron assays revealed behavior and differentiation defects resulting from the R1117X mutant. As mutations in SHANK3 were previously reported in autism, the occurrence of SHANK3 mutations in subjects with a schizophrenia phenotype suggests a molecular genetic link between these two neurodevelopmental disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Carrier Proteins / genetics*
  • Computational Biology
  • DNA Primers / genetics
  • Female
  • Humans
  • Male
  • Microsatellite Repeats / genetics
  • Molecular Sequence Data
  • Mutation, Missense / genetics*
  • Nerve Tissue Proteins / genetics*
  • Neurons / cytology*
  • Pedigree
  • Rats
  • Schizophrenia / genetics*
  • Sequence Analysis, DNA
  • Zebrafish

Substances

  • Carrier Proteins
  • DNA Primers
  • Nerve Tissue Proteins
  • SHANK3 protein, human
  • postsynaptic density proteins